822 related articles for article (PubMed ID: 34012800)
1. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications.
Sedighzadeh SS; Khoshbin AP; Razi S; Keshavarz-Fathi M; Rezaei N
Transl Lung Cancer Res; 2021 Apr; 10(4):1889-1916. PubMed ID: 34012800
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor-associated macrophages in lung cancer: From mechanism to small molecule therapy.
Zhou Y; Qian M; Li J; Ruan L; Wang Y; Cai C; Gu S; Zhao X
Biomed Pharmacother; 2024 Jan; 170():116014. PubMed ID: 38134634
[TBL] [Abstract][Full Text] [Related]
5. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
[TBL] [Abstract][Full Text] [Related]
7. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
9. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
10. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
[TBL] [Abstract][Full Text] [Related]
11. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor-associated macrophages in the tumor microenvironment.
Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
[TBL] [Abstract][Full Text] [Related]
13. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of M2 tumor-associated macrophages in non-small-cell lung cancer.
Li Z; Wang YJ; Zhou J; Umakoshi M; Goto A
Histol Histopathol; 2022 Dec; 37(12):1167-1175. PubMed ID: 35638244
[TBL] [Abstract][Full Text] [Related]
15. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
Ge Z; Ding S
Front Oncol; 2020; 10():590941. PubMed ID: 33224886
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages.
de Groot AE; Pienta KJ
Oncotarget; 2018 Apr; 9(29):20908-20927. PubMed ID: 29755698
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-Activated Protein Kinase Pathway: A Critical Regulator in Tumor-associated Macrophage Polarization.
Neamatallah T
J Microsc Ultrastruct; 2019; 7(2):53-56. PubMed ID: 31293885
[TBL] [Abstract][Full Text] [Related]
19. The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization.
Zheng X; Sarode P; Weigert A; Turkowski K; Chelladurai P; Günther S; Kuenne C; Winter H; Stenzinger A; Reu S; Grimminger F; Stiewe T; Seeger W; Pullamsetti SS; Savai R
Cancer Res; 2023 Jul; 83(14):2345-2357. PubMed ID: 37205635
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages: role in cancer development and therapeutic implications.
Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
